CNS Gene Therapy Spatially and Temporally Modulates Transcriptional Expression of Neurons and Oligodendrocytes in Canavan Disease

被引：0
|
作者：
Lotun, Anoushka [1 ]
Mooney, Morgan [1 ]
Gao, Guangping [1 ]
Gessler, Dominic J. [1 ]
机构：
[1] UMass Chan Med Sch, Horae Gene Therapy Ctr, Worcester, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
691
引用
收藏
页码：345 / 345
页数：1
相关论文
共 50 条
  • [1] Detection of ASPA gene expression and function in oligodendrocytes: involvement of oligodendrocytes in Canavan disease
    Kumar, S
    Sowmyalakshmi, R
    Chang, R
    Daniels, SL
    Philippart, M
    de Vellis, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 100 - 100
  • [2] Detection of ASPA gene expression and function in oligodendrocytes. Involvement of oligodendrocytes in canavan disease
    Kumar, S
    Sowmyalakshmi, R
    Chang, R
    Daniels, SL
    Philippart, M
    de Vellis, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 18 - 18
  • [3] Targeting oligodendrocytes in rAAV mediated gene replacement therapy for Canavan disease
    Jonquieres, G. V.
    Mersmann, N.
    Klugmann, C.
    Harrasta, A.
    Klugmann, M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 289 - 289
  • [4] Gene therapy for Canavan disease?
    Fink, DJ
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (01) : 9 - 10
  • [5] Gene therapy targets Canavan disease
    Steinberg, D
    [J]. SCIENTIST, 2001, 15 (18): : 20 - +
  • [6] Temporally and Spatially Restricted Gene Expression Profiling
    Tallafuss, Alexandra
    Washbourne, Philip
    Postlethwait, John
    [J]. CURRENT GENOMICS, 2014, 15 (04) : 278 - 292
  • [7] Pushing the Limits for Canavan Gene Therapy into Adulthood: Is There an Age Limit for Gene Therapy in CNS Disorders?
    Gessler, Dominic J.
    Li, Danning
    Xu, Hongxia
    Su, Qin
    Matalon, Reuben
    Gao, Guangping
    [J]. MOLECULAR THERAPY, 2016, 24 : S25 - S26
  • [8] Optimized AspA Expression Cassette Dramatically Improves Therapeutic Potency of Systemically Delivered rAAV in CNS Gene Therapy of Canavan's Disease
    Gessler, Dominic J.
    Ahmed, Seemin S.
    Su, Qin
    Matalon, Reuben
    Gao, Guangping
    [J]. MOLECULAR THERAPY, 2014, 22 : S111 - S111
  • [9] CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease
    Leone, P
    Janson, CG
    McPhee, SJ
    During, MJ
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (04) : 487 - 492
  • [10] Targeted aspartoacylase gene therapy reverts Canavan disease
    Starling, Shimona
    [J]. NATURE REVIEWS NEUROLOGY, 2018, 14 (01) : 4 - 4
12345